Skip to main content
. 2013 May 15;6(6):1028–1037.

Figure 3.

Figure 3

Pregnancy-associated hormones up-regulate the expression of CCR3 on DSCs. DSCs were treated respectively with hCG (1.25 kU/l to10 kU/l) (A), progesterone (10-10 M to 10-7 M) (B) or 17β-estradiol (10-10 M to 10-7 M) (C) for 48 h, with vehicle as control. Flow cytometry was performed to analyze the expression of CCR3 on DSCs. Error bars depict the standard deviation of the mean. **P<0.01 compared to the vehicle control.